BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lv S, Zhou X, Li YM, Yang T, Zhang SJ, Wang Y, Jia SH, Peng DT. N6-methyladenine-modified DNA was decreased in Alzheimer’s disease patients. World J Clin Cases 2022; 10(2): 448-457 [PMID: 35097069 DOI: 10.12998/wjcc.v10.i2.448]
URL: https://www.wjgnet.com/2307-8960/full/v10/i2/448.htm
Number Citing Articles
1
Zhaoting Yin, Jianyi Lyu, Guiyang Zhang, Xiaohong Huang, Qinghua Ma, Jinyun Jiang. SoftVoting6mA: An improved ensemble-based method for predicting DNA N6-methyladenine sites in cross-species genomesMathematical Biosciences and Engineering 2024; 21(3): 3798 doi: 10.3934/mbe.2024169
2
Naoko Suga, Yuka Ikeda, Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Satoru Matsuda. In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative DiseasesNeurology International 2023; 15(3): 967 doi: 10.3390/neurolint15030062
3
Paula Martinez-Feduchi, Peng Jin, Bing Yao. Epigenetic modifications of DNA and RNA in Alzheimer’s diseaseFrontiers in Molecular Neuroscience 2024; 17 doi: 10.3389/fnmol.2024.1398026
4
Thanga Harini Sundaramoorthy, Isabel Castanho. The Neuroepigenetic Landscape of Vertebrate and Invertebrate Models of Neurodegenerative DiseasesEpigenetics Insights 2022; 15: 251686572211358 doi: 10.1177/25168657221135848